George Casey

George is Global Chairman of Corporate based in New York. He is recognized as one of the leading M&A practitioners and regularly advises Boards of Directors and management of major companies on strategic M&A transactions, corporate governance, ESG and shareholder relations issues.

George has extensive experience in US domestic and cross-border M&A transactions, ranging from public company deals to complex carve-out sales, spin-offs, acquisitions, strategic investments and joint venture transactions, representing many of the largest US and non-US corporate and investment banking clients.

George combines a very diverse transactional experience with a deep understanding of clients’ businesses across the chemicals, industrials, healthcare, mining and metals, media, cable, technology and telecommunications industries, representing leading multinational corporate clients and sovereign wealth funds.

George has been inducted by Legal 500 into the Corporate/M&A “Hall of Fame,” one of 21 M&A lawyers across the United States who were awarded this recognition, and was named a “Dealmaker of the Year” and “Transatlantic Corporate Dealmaker” by the American Lawyer for his transactional work. George has been included in the 2023 Legal 500 M&A Powerlist: USA and was named by clients as one of nine M&A “Super All-Stars” in the 2021 survey of US M&A lawyers by BTI Consulting.

Chambers quotes clients who describe him as a “phenomenal lawyer” who is “very good at giving very strategic advice” and say that his “experience and perspective…make him one of [their] most trusted advisers.”

Work Highlights

George’s recent deal highlights include*:

• Volkswagen: advising on a pending $5 billion investment and electric vehicle technology joint venture with California EV manufacturer Rivian.
• The Dow Chemical Company: advising on:
  - its transaction with DuPont involving the US$130bn combination of the two companies, its subsequent separation into three publicly traded entities and the resulting US$50bn spin-off of Dow, Inc.
  - its US$5bn Reverse Morris Trust transaction with Olin.
  - its negotiations in connection with the US$17.4bn K-Dow joint venture with PIC of Kuwait and the ensuing arbitration over PIC’s refusal to close, in which Dow was awarded US$2.16bn in damages and costs.
  - its US$4.8bn strategic ownership restructuring of Dow Corning.
  - the US$1.5bn sale of its MEGlobal joint venture interest to EQUATE.
  - its US$1.63bn auction sale of Styron to Bain Capital.
  - its US$1.67bn auction sale of Morton Salt to K+S Aktiengesellschaft.
  - the auction sale of its global polypropylene business to Braskem.
  - its divestiture of the Calcium Chloride business to Occidental Petroleum.
• Celanese: advising on:
  - its US$11bn acquisition of DuPont’s Mobility & Materials business.
  - the restructuring of its 50/50 Korea Engineering Plastics Co. joint venture with Mitsubishi Gas Chemical Company, Inc.
  - the US$1.575bn divestiture of its interest in its Polyplastics joint venture to Daicel Corporation.
• LANXESS: advising on its US$1.075bn acquisition of Emerald Kalama Chemical.
• Liberty Global: advising on:
  - its acquisition of a 4.92% stake in Vodafone Group Plc.
  - its US$9.3bn spin-off of Liberty Latin America.
  - its US$8.2bn acquisition of Cable & Wireless Communications plc.
  - its US$23.3bn acquisition of Virgin Media in a stock and cash merger transaction.
  - its investment in Lions Gate Entertainment.
  - the creation of its tracking stock under English law for operations in Latin America and the Caribbean.
• GlaxoSmithKline: advising on its US$5.1bn acquisition of Tesaro.
• LyondellBasell: advising on its US$2.25bn acquisition of A. Schulman.
• Nokia: advising on:
  - the sale of its HERE digital mapping business to a consortium comprised of Audi AG, BMW Group and Daimler AG.
  - its US$8.1bn acquisition of NAVTEQ.
• The Special Committee of the Board of Directors of Amneal Pharmaceuticals: advising on its acquisition of Kashiv Specialty Pharmaceuticals.
• The Chefs’ Warehouse: advising on its acquisition of Chef Middle East.
• invoX Pharma: advising the wholly owned subsidiary of Sino Biopharmaceutical Limited in connection with its tender offer for F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, for approximately US$161m.
• The Board of Directors of The Chefs’ Warehouse: advising on its interactions and settlement with an activist shareholder.
• The Special Committee of the Board of Directors of Novel Denim: advising on its going-private transaction.
• Novartis: advising on:
  - its US$3.9bn acquisition through a tender offer of Advanced Accelerator Applications S.A.
  - its “white knight” offer for Aventis in connection with an unsolicited offer for Aventis by Sanofi.
  - the US$2.5bn auction sale of its Medical Nutrition business to Nestlé.
  - the auction sale of its Nutrition & Santé business to a private equity buyer.
• SPX Technologies: advising on the sale of its legacy asbestos liability portfolio to an entity owned by Global Risk Capital and Premia Holdings.
• Bojangles’ Inc.: advising on its sale to Durational Capital Management and The Jordan Company in a public company merger transaction.
• KMG Chemicals, Inc.: advising on its US$1.6bn sale to Cabot Microelectronics Corporation in a public company merger transaction.
• Sasol Limited: advising on the sale of its 50% membership interest in its polyethylene joint venture to INEOS.
• Instrumentarium: advising on its US$2.3bn acquisition by GE.
• Anglo American plc: advising on:
  - the sale of its Anglo Norte copper business to a consortium led by Audley Capital Advisors LLP.
  - its US$5.39bn sale of a 24.5% interest in Anglo American Sur, a Chilean copper mining company, to Mitsubishi, its subsequent settlement of a dispute and its US$2.8bn sale of an interest in Anglo American Sur to CODELCO, a Chilean State-owned company, and Mitsui.
  its US$1bn auction sale of Moly Cop and AltaSteel to OneSteel Limited.
• ArcelorMittal: advising on its US$1.1bn sale of a 15% interest in a joint venture comprising ArcelorMittal's Labrador Trough iron ore mining and infrastructure assets in Canada to a consortium led by POSCO of Korea and China Steel Corporation of Taiwan.
• Arcelor: advising on:
  - its US$4.7bn unsolicited offer for Dofasco in Canada.
  - the acquisition of an additional interest in CST in Brazil.
• Pechiney: advising in connection with an initially unsolicited and later recommended US$6.7bn tender offer by Alcan.
• Thomson Reuters: advising on:
  - its US$7.75bn auction sale of Thomson Learning to Apax and OMERS.
  - its acquisition of MarkMonitor.
  - its auction sale of BarBri to a private equity buyer.
  - its divestiture of NETg to SkillSoft.
  - its divestiture of Prometric to ETS.
  - its auction sale of a database to FactSet.
• AngloGold: advising on its US$1.9bn acquisition of Ashanti, a Ghanaian gold mining company.
• Bell Canada International and other shareholders: advising on the US$1bn sale of their interest in Hansol M.com to Korea Telecom.
• Axel Springer: advising in connection with the acquisition of ProSiebenSat.1 Media AG.
• Alcan: advising on its acquisition of the cathodes business of GrafTech International Ltd.

*Includes matters handled prior to joining Linklaters.

Before joining Linklaters, George was the Global Managing Partner of Shearman & Sterling LLP, while continuing his full-time practice. He also previously served as Global Mergers & Acquisitions Practice Group Leader and Global Head of Corporate.

In addition to his work with clients, George is an Adjunct Professor at the University of Pennsylvania Law School where he teaches a course on Mergers and Acquisitions. He is also a regular lecturer on US M&A at l’ École de Droit de la Sorbonne – Université Paris, and a contributing editor of the inaugural Chambers’ Technology M&A Global Practice Guide.

George serves as a member of the Board of Trustees and Chair of the Audit Committee of the American University and American College of Greece, and as a member of the Board of Directors of the Center for European Policy Analysis (CEPA), a Washington DC think tank.

Awards & Market Recognition

• Included in the Legal 500 M&A Powerlist: USA (2023)
• Named by clients as one of nine M&A “Super All-Stars” in a survey of U.S. M&A lawyers by BTI Consulting (2021)
• Named Leading Dealmaker in America by Lawdragon (2021)
• Inducted into the Legal 500 US Corporate/M&A “Hall of Fame” (2020)
• M&A Group led by George ranked #1 Transactional Practice by the Corporate Counsel Readers’ Survey (2020)
• Named Most Influential M&A Lawyer (New York) by Acquisition INTL (2018)
• Named Dealmaker of the Year by The American Lawyer (2016)
• Named Transatlantic Corporate Dealmaker, M&A (U.S.) by The American Lawyer (2016)
• Finalist for the Financial Times Innovative Lawyers Awards (2013, 2016, 2018)
• Awarded M&A Deal of the Year for the US$3.9bn acquisition of Advanced Accelerator Applications S.A. (2019)
• Awarded M&A Deal of the Year for The Dow Chemical Company's carve-out of its chlor-alkali business and merger of the new entity with Olin Corporation through a Reverse Morris Trust transaction. This complex and unique transaction included a carve-out, equity and debt exchanges, and a public company merger (2016)
• M&A Group awarded the M&A Team of the Year by IFLR (2018)
• Chambers quotes clients who describe him as a "phenomenal lawyer" who is "very good at giving very strategic advice" and say that his "experience and perspective…makes him one of [their] most trusted advisers."
• IFLR1000 Leading Lawyer for financial and corporate law (2017)

Conferences

• “Investor Activism,” chair a panel at the Financial Times Outstanding Directors Exchange, June 2023
• “Corporate Governance and Geopolitical Risks,” Salzburg Forum on Corporate Governance, October 2022
• “New Realities in M&A,” chair a panel at the Financial Times Outstanding Directors Exchange, October 2021
• “The Board’s Role in Improving M&A Deal Outcomes,” chair a panel at the Corporate Board Member annual Boardroom Summit, September 2021
• “ESG Considerations in M&A,” presenter at the annual American Bar Association meeting, September 2021
• “Comparative Deal Architecture: Are US and European Deals Built the Same Way?”, chair the Conference Moderated by Chief Justice Leo Strine, March 2020
• “To ESG or Not to ESG? That is no Longer a Question,” chair a panel at the Society for Corporate Governance 2020 Annual Conference, September 2020
• “Shareholder Activism in the COVID-19 Era,” chair a panel at the Financial Times Outstanding Directors Exchange, October 2020
• “Considering ESG in M&A Strategy,” chair a roundtable discussion at the Financial Times Outstanding Directors Exchange, October 2020
• 2020 Annual Boardroom Summit, chair of a panel “Would Your M&A Transaction Withstand a Shareholder Challenge?”, November 2020
• “Picking the Right Poison Pill: Strategies for Preventing Opportunistic Stock Sweeps and Preserving Value,” Webinar, May 2020
• “Current Issues Relating to Spin-Offs: Two-Part Discussion,” Webinar, September 2020
• “Reverse Morris Trust Transactions for the C-Suite,” Webinar, October 2020
• 2019 Annual Boardroom Summit, chair of a panel “M&A Rules of Engagement for the Board,” April 2019
• Transaction Advisors’ 2019 M&A Conference at Wharton San Francisco, chair of a panel “Joint Ventures and Minority Investments,” March 2019
• Transaction Advisors’ 2018 M&A Conference at the University of Chicago, chair of a panel “Cross-Border Acquisition Techniques and Considerations,” 2016-2018 
• Tulane Corporate Law Institute M&A Conference, panelist, March 2017
• “Special Committees of the Board in M&A Transactions,” chair of a panel on Board governance and special committee considerations and best practices, NYSE Annual Boardroom Summit 2011-2017
•  “US or EU: Which has – as a Matter of Fact – A More Open Market for Corporate Control,” chair of a conference moderated by Chief Justice Leo Strine, February 2014
• “Special Committees of the Board in M&A Transactions”—featured in a Corporate Board Member “Board Member Series” video interviews
• “What to Do When an Acquiror Knocks?”—chair a panel on how the Board of Directors and senior executives should respond to an unsolicited takeover proposal at the Annual Boardroom Summit

• “Technology M&A Overview and Introduction”, as contributing editor, of Chambers’ Technology M&A Guide, Chambers’ 2022, 2023 and 2024 Global Practice Guides, December 2021, 2022 and 2023
• “'Ordinary Course of Business' During Not-So Ordinary Times,” M&A Watch, December 2021
• “Recent Shareholder Activism Trends,” 2021 Corporate Governance Survey, November 2021
• “'Mission Critical' Board Oversight,” M&A Watch, November 2021 “Contractual Limits on Liability Only Go So Far in Delaware,” Law360, September 2021
• “Four Key Areas in M&A and Governance Boards Should Focus on Post Pandemic,” the Corporate Board Member Magazine, September 2021
• “Delaware Court Rejects Buyer’s Claim of an MAE,” Harvard Forum on Corporate Governance, August 2021
• “A Wrong Poison Pill,” Corporate Board Member, March 2021
• “M&A: Looking Back/Looking Forward: Key Takeaways for Boards from 2020 and Likely Trends for the Coming Year,” Corporate Board Member, January 2021
• “Governance Amid Crisis,” the Corporate Board Member Magazine, First Quarter 2021
• “Effects of COVID-19 on Shareholder Activism and M&A: Views from Corporate Boards and the Market,” Corporate Board Member, October 2020
• “ESG Considerations in M&A,” M&A Lawyer, August 2020, and Corporate Board Member, September 2020
• “Seeking Your True Purpose? Delaware Offers Guidance on Section 220 requests,” November 2019, M&A Watch
• “New Regulations Significantly Expand CFIUS Reach,” M&A Watch, September 2019
• “Caremark Unfrozen: Delaware Supreme Court Revisits Oversight Claims,” M&A Watch, July 2019
• “How to Get a Big “MAC” in Delaware,” M&A Watch, October 2018
• “FTC Warning: Don’t Overshare in Pending Deals,” M&A Watch, April 2018
• “Ant Financial and MoneyGram Terminate Merger Agreement Due to CFIUS Concerns,” M&A Watch, January 2018
• “That’s the Way the Cookie Crumbles: Delaware Court Rejects MAE Claim in Commercial Contract Negotiation,” M&A Watch, July 2017
• “Shareholders and Boards of Directors in US Mergers and Acquisitions,” chapter in The Mergers & Acquisitions Review, Fifth, Sixth and Seventh Edition, Law Business Research